OPC 2025: You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Author(s)Hanna Yakubi, PharmD, Cody Angerman, PharmD, Iris Zhao, PharmD, BCOP, BCPS, APh

Fact checked by: Gillian McGovern, Editor

This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025.

The increasing use of herbal supplements among patients undergoing cancer treatment, particularly those on oral therapies, presents a significant and often unaddressed challenge in oncology care. Despite the potential for harmful drug-herb interactions that can compromise treatment efficacy and patient safety, many patients do not disclose their supplement use to their health care providers.